Clinical benefit and quality of life in patients with advanced pancreatic cancer receiving gemcitabine plus capecitabine versus gemcitabine alone: A randomized multicenter phase III clinical trial - SAKK 44/00-CECOG/PAN.1.3.001

Jürg Bernhard, Daniel Dietrich, Werner Scheithauer, Daniela Gerber, György Bodoky, Thomas Ruhstaller, Bengt Glimelius, Emilio Bajetta, Johannes Schüller, Piercarlo Saletti, Jean Bauer, Arie Figer, Bernhard C. Pestalozzi, Claus Henning Köhne, Walter Mingrone, Salomon M. Stemmer, Karin Tàmas, Gabriela V. Kornek, Dieter Koeberle, Richard Herrmann

Research output: Contribution to journalArticle

74 Citations (Scopus)

Fingerprint Dive into the research topics of 'Clinical benefit and quality of life in patients with advanced pancreatic cancer receiving gemcitabine plus capecitabine versus gemcitabine alone: A randomized multicenter phase III clinical trial - SAKK 44/00-CECOG/PAN.1.3.001'. Together they form a unique fingerprint.

Medicine & Life Sciences